Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

Amsterdam, May 26, 2010 (ots/PRNewswire) -

NEWS HIGHLIGHTS
- Intel is expanding availability of the Intel Health Guide
across Europe to help address chronic care challenges
- Intel is working with strategic partners in France, Germany,
Spain and The Netherlands to bring localised versions of the Intel
Health Guide to market over the coming year

Intel announced today at the World Congress for Information
Technology that it will be expanding availability of the Intel(R)
Health Guide in Europe and is working with strategic industry
partners in France, Germany, Spain and The Netherlands to bring
localised versions of the Intel Health Guide to market over the
coming year.

The Intel Health Guide(b), a regulated device that carries the CE
mark under the EU Medical Device Directive, combines an in-home
patient device, the Intel Health Guide PHS6000, with the Intel Health
Care Management Suite, an online interface that allows clinicians to
securely monitor patients in their homes and manage care remotely. It
was designed to help address the challenges of chronic conditions for
patients, their family caregivers and the healthcare professionals
responsible for their care.

"Chronic conditions can account for 70 percent of total health
expenditure in Europe, especially if the conditions are poorly
managed.[1] With the average age of the population in Europe
increasing, the number of people with chronic conditions will
increase substantially over the coming years," said Doug Busch, Vice
President and Chief Technical Officer of Intel's Digital Health
Group. "The announcement today represents a major step forward in
addressing new models of care. It demonstrates an industry commitment
to developing the personal health market globally, with the goal of
utilising technology to improve the lives of seniors and people
living with chronic illness."

Addressing the challenges of an ageing population is a goal
shared by the European Commission, which recently adopted its
European Action Plan - Ageing Well in the Information Society. The
plan highlights the key role of information and communication
technologies in providing older people with a better quality of life
and in reducing costs for both health and social care. Between now
and 2013, the EU and its member states will invest more than EUR1
billion in research and innovation in these technologies.

Intel's commitment to addressing the global challenges of an
ageing population

The Intel Health Guide is already commercially available in the
United Kingdom, United States, Ireland and Australia. In The
Netherlands, the localised language Intel Health Guide is now
available and Fujitsu is the first market reseller to sell the Intel
Health Guide. In addition, Intel is working with the Martini Hospital
and CurIT in Groningen to conduct a pilot project using the Intel
Health Guide, funded through local and European subsidies. In this
project, the Intel Health Guide is used for pregnant women with
diabetes.

Intel is also continuing to work with other leading market
channel partners to bring the Intel Health Guide to market globally,
and additional localised European language versions of the Intel
Health Guide will be announced later this year.

- In France, Intel recently announced its collaboration with
Orange Healthcare and plans to cooperate on a telehealth pilot project
with the Moulins-Yzeure Hospital in the Auvergne region of France to
support care of chronic obstructive pulmonary disease (COPD) patients
post-discharge using the Intel Health Guide.
- In Germany, the Asklepios Hospital Group - one of Europe's
largest private Hospital Groups - recently announced a new
eHealth-Services strategy and partner model to provide innovative
eHealth mobile, online and home health services and solutions.
Asklepios and Intel will cooperate on a joint telehealth pilot project
to support care of Asklepios patients post-discharge using the Intel
Health Guide.
- In Spain, Telefonica is working with Intel on a pilot project and
plans to announce first findings later this year.
- In the United Kingdom, BT is the latest market partner selling the
Intel Health Guide. GE Healthcare and Intel recently announced a sales
and marketing agreement for the Intel Health Guide in the United
Kingdom. GE Healthcare already markets the Intel Health Guide in the
United States.

A comprehensive personal health system

The Intel Health Guide allows clinicians to monitor patients in
their homes and manage care remotely via a secure server. It was
designed to help address the challenges of chronic conditions for
patients, their family, carers and the health care professionals
responsible for their care. The system offers interactive tools for
personalised care management and includes vital signs collection,
patient reminders, surveys, multimedia educational content, and
feedback and communications tools such as video conferencing and
email notifications. It can connect to specific models of wired and
wireless medical devices, including blood pressure monitors, glucose
meters, pulse oximeters, peak flow meters and weight scales.

Using a secure server, health care professionals can remotely
review and act on this information. As a result, clinicians have
ongoing access to data so that they can better manage each patient's
conditions. Patients benefit from customised care in the comfort of
their home and can also monitor their health status and communicate
with care teams.

The localised versions of the Intel Health Guide are
Continua-compliant, signalling Intel's commitment to standardisation
and interoperability. The Continua-compliant English language version
will be released later this year. In June 2006, Intel and other
founding member companies announced the formation of the Continua
Health Alliance. Today, the Alliance has over 200 members from
business and representative organisations. This open industry group
seeks to ensure that health technologies are compatible, meet common
standards and work seamlessly together. The main focus of the
Alliance is on creating guidelines for industry across three major
categories: chronic disease management, monitoring the health and
healthcare needs of ageing people and proactive health and fitness.

About Intel

Intel , the world leader in silicon innovation, develops
technologies, products and initiatives to continually advance how
people work and live. Additional information about Intel is available
at http://www.intel.com/pressroom and blogs.intel.com.

For more information on the Intel Health Guide, visit
http://www.intel.com/healthcare/telehealth. To learn more about Intel
in healthcare, go to http://www.intel.com/healthcare. Intel is a
trademark of Intel Corporation or its subsidiaries in the United
States and other countries.

* Other names and brands may be claimed as the property of others

(a) The Intel Health Guide requires an internet connection to
enable communications with the patient's care team and back-end data
hosting. The Intel Health Guide is intended for use by patients under
the guidance of a healthcare professional and is not intended for
emergency medical communications or real-time patients monitoring.

(b) The Intel Health Guide is designed to be used by health care
professionals to manage their patients at home and is not currently
available for general consumer purchase.

Reference [1] Eurostat. Available at: http://epp.eurostat.ec.euro
pa.eu/portal/page?_pageid=1090,30070682,1090_33076
576&_dad=portal&_schema=PORTAL

(Due to the length of this URL, it may be necessary to copy and
paste this hyperlink into your Internet browser's URL address field.
Remove the space if one exists.)

ots Originaltext: Intel
Im Internet recherchierbar: http://www.presseportal.de

Contact:
CONTACT: CONTACTS: Diana Kaaserer, Intel Corporation,
+49-8999143860,diana.kaaserer@intel.com ; Bea Solomon, Hill and
Knowlton, +44-2074133188,bsolomon@hillandknowlton.com